• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The penetration of rifampicin, pyrazinamide, and pyrazinoic acid into mouse macrophages.

作者信息

Acocella G, Carlone N A, Cuffini A M, Cavallo G

出版信息

Am Rev Respir Dis. 1985 Dec;132(6):1268-73. doi: 10.1164/arrd.1985.132.6.1268.

DOI:10.1164/arrd.1985.132.6.1268
PMID:4073666
Abstract

The degree of penetration of rifampicin, pyrazinamide, and its metabolite pyrazinoic acid in mouse macrophages was evaluated over a period of 24 h. Cell cultures were exposed to 14C-labeled drugs at concentrations corresponding to peak, trough, and intermediate serum concentrations observed in humans after administration of therapeutic doses. The study was carried out with dead, resident, and stimulated peritoneal macrophages. The results indicated that the 3 compounds penetrate macrophages rapidly. At the lower concentrations, uptake of the 3 drugs is practically complete. With increasing concentrations, the absolute amount in the intracellular compartment increased. Comparison of the degree of penetration of the 3 drugs into dead, resident, and stimulated macrophages seems to suggest that the process of transfer through the macrophage wall is of a passive nature and not related to the metabolic state of the cells. Analysis of the binding of the 3 drugs to intracellular proteins indicated that more binding sites are probably available for rifampicin than for the other 2 drugs.

摘要

相似文献

1
The penetration of rifampicin, pyrazinamide, and pyrazinoic acid into mouse macrophages.
Am Rev Respir Dis. 1985 Dec;132(6):1268-73. doi: 10.1164/arrd.1985.132.6.1268.
2
Killing of macrophage-ingested mycobacteria by rifampicin, pyrazinamide, and pyrazinoic acid alone and in combination.利福平、吡嗪酰胺和吡嗪酸单独及联合使用对巨噬细胞吞噬的分枝杆菌的杀灭作用。
Am Rev Respir Dis. 1985 Dec;132(6):1274-7. doi: 10.1164/arrd.1985.132.6.1274.
3
Kinetics of the uptake of rifampicin and tetracycline into mouse macrophages. In vitro study of the early stages.
Pathol Biol (Paris). 1984 Feb;32(2):85-9.
4
The penetration of dapsone, rifampicin, isoniazid and pyrazinamide into peripheral nerves.氨苯砜、利福平、异烟肼和吡嗪酰胺在外周神经中的渗透情况。
Br J Pharmacol. 1975 Sep;55(1):151-5. doi: 10.1111/j.1476-5381.1975.tb07623.x.
5
Comparative effects of roxithromycin and erythromycin on cellular immune functions in vitro. 1. Uptake of 3H-macrolides by human macrophages.罗红霉素与红霉素对体外细胞免疫功能的比较作用。1. 人巨噬细胞对³H-大环内酯类药物的摄取。
Microbios. 1989;57(232-233):167-78.
6
Pyrazinoic acid decreases peritoneal transfer rates.吡嗪酸可降低腹膜转运速率。
Adv Perit Dial. 1995;11:33-5.
7
The bioavailability of isoniazid, rifampin, and pyrazinamide in two commercially available combined formulations designed for use in the short-course treatment of tuberculosis.两种用于结核病短程治疗的市售联合制剂中异烟肼、利福平及吡嗪酰胺的生物利用度。
Am Rev Respir Dis. 1986 Jun;133(6):1076-80. doi: 10.1164/arrd.1986.133.6.1076.
8
Metabolic disposition of pyrazinamide in the rat: identification of a novel in vivo metabolite common to both rat and human.
Biopharm Drug Dispos. 1987 Jul-Aug;8(4):307-18. doi: 10.1002/bdd.2510080402.
9
Activity in vitro of rifabutin, FCE 22807, rifapentine, and rifampin against Mycobacterium microti and M. tuberculosis and their penetration into mouse peritoneal macrophages.利福布汀、FCE 22807、利福喷汀和利福平对田鼠分枝杆菌和结核分枝杆菌的体外活性及其对小鼠腹腔巨噬细胞的穿透能力。
Am Rev Respir Dis. 1992 Jan;145(1):212-4. doi: 10.1164/ajrccm/145.1.212.
10
Bioavailability of rifampicin, isoniazid and pyrazinamide from fixed-dose combination capsules.固定剂量复方胶囊中利福平、异烟肼和吡嗪酰胺的生物利用度。
Int J Tuberc Lung Dis. 1998 Oct;2(10):824-30.

引用本文的文献

1
Inflammasome-mediated glucose limitation induces antibiotic tolerance in .炎性小体介导的葡萄糖限制诱导……中的抗生素耐受性 。(原句不完整)
iScience. 2023 Sep 17;26(10):107942. doi: 10.1016/j.isci.2023.107942. eCollection 2023 Oct 20.
2
Recalcitrant Staphylococcus aureus Infections: Obstacles and Solutions.耐药性金黄色葡萄球菌感染:障碍与解决方案。
Infect Immun. 2021 Mar 17;89(4). doi: 10.1128/IAI.00694-20.
3
Reactive oxygen species induce antibiotic tolerance during systemic Staphylococcus aureus infection.活性氧诱导系统金黄色葡萄球菌感染期间的抗生素耐药性。
Nat Microbiol. 2020 Feb;5(2):282-290. doi: 10.1038/s41564-019-0627-y. Epub 2019 Dec 9.
4
Impact of the host environment on the antitubercular action of pyrazinamide.宿主环境对吡嗪酰胺抗结核作用的影响。
EBioMedicine. 2019 Nov;49:374-380. doi: 10.1016/j.ebiom.2019.10.014. Epub 2019 Oct 25.
5
Primary Lung Dendritic Cell Cultures to Assess Efficacy of Spectinamide-1599 Against Intracellular .用于评估司帕酰胺-1599对细胞内病原体疗效的原代肺树突状细胞培养物
Front Microbiol. 2018 Aug 21;9:1895. doi: 10.3389/fmicb.2018.01895. eCollection 2018.
6
Clinical pharmacology and lesion penetrating properties of second- and third-line antituberculous agents used in the management of multidrug-resistant (MDR) and extensively-drug resistant (XDR) tuberculosis.用于耐多药(MDR)和广泛耐药(XDR)结核病管理的二线和三线抗结核药物的临床药理学及病灶穿透特性
Curr Clin Pharmacol. 2010 May;5(2):96-114. doi: 10.2174/157488410791110797.
7
Effect of sex and AIDS status on the plasma and intrapulmonary pharmacokinetics of rifampicin.性别和艾滋病状态对利福平血浆及肺内药代动力学的影响。
Clin Pharmacokinet. 2004;43(6):395-404. doi: 10.2165/00003088-200443060-00003.
8
Pharmacokinetics-pharmacodynamics of rifampin in an aerosol infection model of tuberculosis.利福平在肺结核气溶胶感染模型中的药代动力学-药效学
Antimicrob Agents Chemother. 2003 Jul;47(7):2118-24. doi: 10.1128/AAC.47.7.2118-2124.2003.
9
Intrapulmonary concentrations of pyrazinamide.吡嗪酰胺的肺内浓度。
Antimicrob Agents Chemother. 1999 Jun;43(6):1329-33. doi: 10.1128/AAC.43.6.1329.
10
Entry of sanfetrinem into human polymorphonuclear granulocytes and its cell-associated activity against intracellular, penicillin-resistant Streptococcus pneumoniae.三苯菌素进入人多形核粒细胞及其对细胞内耐青霉素肺炎链球菌的细胞相关活性。
Antimicrob Agents Chemother. 1998 Jul;42(7):1745-50. doi: 10.1128/AAC.42.7.1745.